Cargando…

Long-term clinical outcomes of adults with metabolic dysfunction-associated fatty liver disease: a single-centre prospective cohort study with baseline liver biopsy

BACKGROUND: There are limited data on the long-term adverse clinical outcomes of adults with metabolic dysfunction-associated fatty liver disease (MAFLD). METHODS: This is a single-centre prospective study of a well-characterized cohort of MAFLD patients who underwent liver biopsy and followed every...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chan, Wah-Loong, Chong, Shi-En, Chang, Felicia, Lai, Lee-Lee, Chuah, Kee-Huat, Nik Mustapha, Nik Raihan, Mahadeva, Sanjiv, Chan, Wah-Kheong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer India 2023
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10218774/ https://www.ncbi.nlm.nih.gov/pubmed/37237087 http://dx.doi.org/10.1007/s12072-023-10550-9

Ejemplares similares

Serum Wisteria floribunda agglutinin-positive Mac-2 binding protein in non-alcoholic fatty liver disease
por: Lai, Lee-Lee, et al.
Publicado: (2017)

Limited Utility of Plasma M30 in Discriminating Non-Alcoholic Steatohepatitis from Steatosis – A Comparison with Routine Biochemical Markers
por: Chan, Wah-Kheong, et al.
Publicado: (2014)

Non-invasive biomarkers for liver inflammation in non-alcoholic fatty liver disease: present and future
por: Chuah, Kee-Huat, et al.
Publicado: (2023)

Copy number variation in exportin-4 (XPO4) gene and its association with histological severity of non-alcoholic fatty liver disease
por: Zain, Shamsul Mohd, et al.
Publicado: (2015)

Limited applicability of cathepsin D for the diagnosis and monitoring of non‐alcoholic steatohepatitis
por: Kamarajah, Sivesh K, et al.
Publicado: (2019)

Validation model of fibrosis-8 index score to predict significant fibrosis among patients with nonalcoholic fatty liver disease
por: Prasoppokakorn, Thaninee, et al.
Publicado: (2022)

Epidemiological differences of common liver conditions between Asia and the West
por: Jayaraman, Thevaraajan, et al.
Publicado: (2019)

Malaysian Society of Gastroenterology and Hepatology consensus statement on metabolic dysfunction‐associated fatty liver disease
por: Chan, Wah‐Kheong, et al.
Publicado: (2022)

Attenuation parameter and liver stiffness measurement using FibroTouch vs Fibroscan in patients with chronic liver disease
por: Ng, Ying Zhuang, et al.
Publicado: (2021)

Association between non‐alcoholic fatty liver disease evaluated by transient elastography with extracranial carotid atherosclerosis in a multiethnic Asian community
por: Tan, Eugene Choon‐Li, et al.
Publicado: (2018)

Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): A State-of-the-Art Review
por: Chan, Wah-Kheong, et al.
Publicado: (2023)

Comparison between obese and non-obese nonalcoholic fatty liver disease
por: Chan, Wah-Kheong
Publicado: (2023)

Use of simple scoring systems for a public health approach in the management of non‐alcoholic fatty liver disease patients
por: Zain, Shamsul Mohd, et al.
Publicado: (2020)

Appointment waiting times and education level influence the quality of bowel preparation in adult patients undergoing colonoscopy
por: Chan, Wah-Kheong, et al.
Publicado: (2011)

Cultural Factors Influencing Functional Gastrointestinal Disorders in the East
por: Chuah, Kee-Huat, et al.
Publicado: (2018)

Defining the irritable bowel
por: Chuah, Kee Huat, et al.
Publicado: (2022)

The challenges of implementing evidence‐based therapy for irritable bowel syndrome in Asia
por: Chuah, Kee‐Huat, et al.
Publicado: (2021)

Non-invasive assessment of metabolic dysfunction–associated fatty liver disease
por: Chandra Kumar, C. Vikneshwaran, et al.
Publicado: (2022)

Epidemiology of non‐alcoholic fatty liver disease‐related hepatocellular carcinoma and its implications
por: Wong, Sui‐Weng, et al.
Publicado: (2018)

Fibroscan-AST (FAST) score and other non-invasive tests for the diagnosis of fibrotic non-alcoholic steatohepatitis
por: Chan, Wah Loong, et al.
Publicado: (2023)

Genome-Wide Analysis of Copy Number Variation Identifies Candidate Gene Loci Associated with the Progression of Non-Alcoholic Fatty Liver Disease
por: Zain, Shamsul Mohd, et al.
Publicado: (2014)

The association of body mass index with functional dyspepsia is independent of psychological morbidity: A cross-sectional study
por: Beh, Keng Hau, et al.
Publicado: (2021)

Predictors of advanced fibrosis in elderly patients with biopsy-confirmed nonalcoholic fatty liver disease: the GOASIA study
por: Pitisuttithum, Panyavee, et al.
Publicado: (2020)

Evaluation of Patient Satisfaction of an Outpatient Colonoscopy Service in an Asian Tertiary Care Hospital
por: Chan, Wah-Kheong, et al.
Publicado: (2012)

Evaluation of patient satisfaction of an outpatient gastroscopy service in an Asian tertiary care hospital
por: Azmi, Najib, et al.
Publicado: (2012)

Prevalence of metabolic syndrome and metabolic dysfunction-associated fatty liver disease in Malaysia 2023: study protocol for a community-based nationwide cross-sectional survey
por: Wan, Kim Sui, et al.
Publicado: (2023)

Gastrointestinal Dysfunction in Parkinson’s Disease: Neuro-Gastroenterology Perspectives on a Multifaceted Problem
por: Tan, Ai Huey, et al.
Publicado: (2023)

Clinicopathological Comparison of Adenocarcinoma of Cervix and Endometrium Using Cell Cycle Markers: P16ink4a, P21waf1, and p27Kip1 on 132 Cancers
por: Marican Abu Backer, Farveen, et al.
Publicado: (2011)

Acquiring new complex endoscopic skills: Experience from the development of peroral endoscopic myotomy (POEM) in Malaysia
por: Ho, Shiaw Hooi, et al.
Publicado: (2021)

Calculated parameters for the diagnosis of Wilson disease
por: Zulkufli, Nada Syazana, et al.
Publicado: (2022)

Diagnosis of Fibrosis Using Blood Markers and Logistic Regression in Southeast Asian Patients With Non-alcoholic Fatty Liver Disease
por: Sang, Chao, et al.
Publicado: (2021)

Complications of percutaneous liver biopsy in living donor liver transplantation: Two case reports
por: Chiu, King-Wah, et al.
Publicado: (2018)

Gamma-glutamyl transferase and cardiovascular risk in nonalcoholic fatty liver disease: The Gut and Obesity Asia initiative
por: Pitisuttithum, Panyavee, et al.
Publicado: (2020)

Kombiglyze (metformin and saxagliptin)‐induced hepatotoxicity in a patient with non‐alcoholic fatty liver disease
por: Thalha, Abdul Malik, et al.
Publicado: (2018)

Translation, adaptation and validation of two versions of the Chronic Liver Disease Questionnaire in Malaysian patients for speakers of both English and Malay languages: a cross-sectional study
por: Khairullah, Shasha, et al.
Publicado: (2017)

Loss-of-function HSD17B13 variants, non-alcoholic steatohepatitis and adverse liver outcomes: Results from a multi-ethnic Asian cohort
por: Ting, Yi-Wen, et al.
Publicado: (2021)

Mesenchymal stem cell therapy for advanced liver cirrhosis: A case report
por: Rajaram, Ruveena, et al.
Publicado: (2017)

The impact of the COVID‐19 pandemic on patients with chronic liver disease: Results from the Global Liver Registry
por: Younossi, Zobair M., et al.
Publicado: (2022)

COVID‐19 and the digestive system: More than just a “flu”
por: Goh, Khean‐Lee, et al.
Publicado: (2020)

Feasibility and Stability of Liver Biopsy before Treatment for Preclinical Nonalcoholic Fatty Liver Studies
por: Chae, Yeon Ji, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_ci54vojseqf4tn2k9kfpmu1r2e